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Background/Aims: Vitamin D may have a protective role in the develop-
ment of many chronic diseases, including T2DM. The aim of this study was
to investigate the association between serum 25OHD, the risk of T2DM and
presence of the metabolic syndrome (MetS).
Methods: We analysed the 2009-2010 Victorian Health Monitor survey
where information on 25OHD, HBA1c, fasting plasma glucose and pres-
ence of the metabolic syndrome were available. Logistic regression ana-
lyses were used to evaluate the association between tertiles of serum
25OHD and HbA1c (< 5.7% vs. 5.7%), fasting plasma glucose (< 5.6 mmol/
L vs.  5.6 mmol/L) and MetS (yes/no). Confounders tested were age,
gender, country of birth, income, education, physical activity, smoking
status, season, weight, calcium, magnesium, energy intake, television
viewing time, sitting time, waist circumference, BMI, and intakes of
alcohol, total fat, carbohydrate, protein, retinol, ﬁbre and caffeine.
Results: A total of 3434 Australian adults excluding those with T1DM and
T2DM entered the analysis. Greater 25OHD had a lower OR of being
associated with the presence of MetS [OR 0.36 (95% CI; 0.27, 0.48), p ¼
0.005], lower OR of a higher HbA1c [OR 0.62 (95% CI; 0.49, 0.77), p ¼
0.004], and a lower OR of higher fasting plasma glucose [OR 0.55 (95% CI;
0.39, 0.77), p ¼ 0.004].
Conclusions: Higher 25OHD may have a beneﬁcial effect on MetS and risk
of T2DM.
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Background/Aims: Vitamin D has anti-proliferative, pro-differentiative
and immune-modulating effects. We aimed to determine whether raising
serum 25(OH)D through vitamin D3 supplementation improves psoriasis.
Methods: In a randomised (2:1), double-blind, placebo-controlled trial,
101 participants > 18 y with plaque psoriasis took 200,000 International
Units (IU) of cholecalciferol at baseline then 100,000 IU/month for 11
months (n ¼ 67), or placebo (n ¼ 34). Psoriasis Area and Severity Index
(PASI) and serum 25(OH)D concentration were assessed at baseline, 3m,
6m, 9m and 12m. Primary outcomes were a) difference in PASI between
groups over time, and b) the relationship between PASI and 25(OH)D over
time, assessed by linear mixed models adjusted for confounding and/or
individual factors.
Results: There was a signiﬁcant inverse relation-ship between 25(OH)D
and PASI. Elevating serum 25(OH)D by increments from 25 e 125nmol/L
was associated with mild decreases in PASI (estimated range of decrease
0 e 2.6; p ¼ 0.002). PASI did not differ by group (p ¼ 0.62, group*time p ¼
0.54), and an improvement in PASI of 50% or higher was achieved by 11.9%
of treatment and 11.8% of placebo. However, mean 25(OH)D signiﬁcantly
increased from baseline at 3m for treatment [b¼ 33 (95% CI 28e 38) nmol/
L, p< 0.001] and 6m for placebo [b¼ 24 (95% CI 17e 30) nmol/L, p < 0.001],
possibly confounding these results.
Conclusions: At a population level, elevating serum 25(OH)D is associated
with improved psoriasis. Estimated improvements were mild at 25(OH)D
concentrations in this study and may not be clinically signiﬁcant; higher
concentrations could have greater beneﬁt.
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Background/Aims: In contrast to some epidemiological evidence our
previous research found that a 4-week diet high in dairy reduced insulin
sensitivity compared to one high in red meat. Our aim was to investigate
whether a dairy meal produced lower glucose compared with a carbohy-
drate-matched red meat meal.
Methods: A total of 19 men and 24 women (age 50.8 ± 16.0, BMI 30.0 ± 3.5
kg/m2) completed the randomized crossover study. Twenty-two partici-
pants had normal glucose tolerance; 21 had impaired fasting glucose and/
or impaired glucose tolerance. One meal contained lean red meat, bread
and orange juice and the other milk, yoghurt, cheese and bread. Meals
were isoenergetic, equal in macronutrient proﬁle and consumed one week
apart. Glucose and insulin were measured before and 30, 60, 90, 120, 150
and 180 minutes after consuming the meal. Difference between meals was
tested using repeated measures ANOVA and paired sample T-tests.
Results: The red meat meal resulted in a higher glucose response at T30 (p
< 0.001) however total glucose AUC was not different between meals (p ¼
NS). Incremental AUC for glucose was signiﬁcantly higher after the dairy
meal (2.23 ± 3.19 mmol/L vs. 0.88 ± 3.73 mmol/L, p ¼ 0.004). Total and
incremental insulin AUC was not different between meals (iAUC 159.65
mU/L for red meat, vs. 167.49 mU/L for dairy, p ¼ NS).
Conclusions: Lean red meat and dairy meals produced a similar glycemic
response. The higher glucose response 30 minutes after the red meat meal
is likely attributable to differences in glycemic load between orange juice
and milk or yoghurt. An insulinotropic effect of dairy was not observed.
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Background/Aims: Inﬂammation of the mammary gland (mastitis) caused
by invading pathogens is common among lactating dairy cows and causes
great economic losses. We recently demonstrated that Chinese propolis
(CP), a resinous substance collected by honeybees, can positively inﬂuence
anti-inﬂammatory processes and antioxidant defense systems in vivo but
little is known about how propolis treatment of mastitis in dairy cows may
inﬂuence these activities.
Methods: We investigated the potentially protective effects of CP on as-
pects of mastitis by using an in vitromodel of mastitis-induced cell damage
involving cultured bovine mammary epithelial cells (MAC-T) which
received a range of mastitis pathogen-related insults. Cell viability was
measured by cell counting kit (CCK)-8 cell viability assay and expression of
inﬂammatory or antioxidant genes were measured by qPCR. Using a cell-
based reporter assay system, we evaluated CP and its main constituents’ on
NF-kB and Nrf2-ARE transcription activity.
Results: Treatment of cells with cell wall components lipopolysaccharide
(LPS), heat inactivated E. coli and S. aureus, but not TNF-a or lipo-teichoic
acid (LTA), signiﬁcantly decreased cell viability (p < 0.01). CP pretreatment
(15 mg/mL) signiﬁcantly (p < 0.05) protected cell viability losses. CP pre-
treatment of MAC-T cells resulted in less impact on IL-6 and TNF-a mRNA
expressions but increased expression of antioxidant genes HO-1, Txnrd-1
and GCLM. CP and its polyphenolic active components (mainly CAPE and
quercetin) had strong inhibitive effects against NF-kB and increased the
transcriptional activation of the Nrf2-ARE pathway.
Conclusions: Our ﬁndings support the usage of dietary propolis for the
treatment of bovine mastitis.
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